New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12 - PubMed (original) (raw)
. 2003 May 15;12(10):1111-20.
doi: 10.1093/hmg/ddg131.
Affiliations
- PMID: 12719375
- DOI: 10.1093/hmg/ddg131
New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12
Franco Pagani et al. Hum Mol Genet. 2003.
Abstract
The increase in genome scanning data, derived from clinical genetics practice, is producing a wealth of information on human sequence variability. The critical issue is to identify if a given nucleotide change results in a benign polymorphism or a disease-causing mutation. We have focused on one specific gene expression step, pre-mRNA processing, where we can functionally define the effect of nucleotide changes and in turn the patient's mutation can shed light on the basic pre mRNA splicing mechanisms. Our results show that several nucleotide changes in CFTR exon 12 induce a variable extent of exon skipping that leads to reduced levels of normal transcripts. This is the case in both natural mutations D565G and G576A (the latter having previously considered a neutral polymorphism) and several site-directed silent substitutions. We demonstrate here that this phenomenon is due to the interference with a new regulatory element that we have named composite exonic regulatory element of splicing (CERES). The effect of single nucleotide substitutions at CERES cannot be predicted by neither SR matrices nor enhancer identification. The recognition and characterization of splicing abnormalities, caused by exon sequence variations at CERES elements, may represent a frequent disease-causing mechanism that also relates to the phenotypic variability. Our results indicate that even the most benign looking polymorphism in an exon cannot be ignored as it may affect the splicing process. Hence, appropriate functional splicing assays should be included in genotype screenings to distinguish between polymorphisms and pathogenic mutations.
Similar articles
- Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.
Pagani F, Buratti E, Stuani C, Baralle FE. Pagani F, et al. J Biol Chem. 2003 Jul 18;278(29):26580-8. doi: 10.1074/jbc.M212813200. Epub 2003 May 5. J Biol Chem. 2003. PMID: 12732620 - Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E. Kerem E. Pediatr Pulmonol. 2005 Sep;40(3):183-96. doi: 10.1002/ppul.20200. Pediatr Pulmonol. 2005. PMID: 15880796 Review. - Mutation specific therapy in CF.
Kerem E. Kerem E. Paediatr Respir Rev. 2006;7 Suppl 1:S166-9. doi: 10.1016/j.prrv.2006.04.213. Epub 2006 Jun 5. Paediatr Respir Rev. 2006. PMID: 16798551 Review.
Cited by
- A self-repair history: compensatory effect of a de novo variant on the FANCA c.2778+83C>G splicing mutation.
Persico I, Fontana G, Faleschini M, Zanchetta ME, Ammeti D, Cappelli E, Corsolini F, Mosa C, Guarina A, Bogliolo M, Surrallés J, Dufour C, Farruggia P, Savoia A, Bottega R. Persico I, et al. Front Genet. 2023 Jul 20;14:1209138. doi: 10.3389/fgene.2023.1209138. eCollection 2023. Front Genet. 2023. PMID: 37547463 Free PMC article. - Splicing mutations in the CFTR gene as therapeutic targets.
Deletang K, Taulan-Cadars M. Deletang K, et al. Gene Ther. 2022 Aug;29(7-8):399-406. doi: 10.1038/s41434-022-00347-0. Epub 2022 Jun 2. Gene Ther. 2022. PMID: 35650428 Free PMC article. Review. - Frequency of allele variations in the CFTR gene in a Mexican population.
Cantú-Reyna C, Galindo-Ramírez R, Vázquez-Cantú M, Haddad-Talancón L, García-Muñoz W. Cantú-Reyna C, et al. BMC Med Genomics. 2021 Nov 5;14(1):262. doi: 10.1186/s12920-021-01111-w. BMC Med Genomics. 2021. PMID: 34740355 Free PMC article. - Intermixing the OPN1LW and OPN1MW Genes Disrupts the Exonic Splicing Code Causing an Array of Vision Disorders.
Neitz M, Neitz J. Neitz M, et al. Genes (Basel). 2021 Jul 29;12(8):1180. doi: 10.3390/genes12081180. Genes (Basel). 2021. PMID: 34440353 Free PMC article. Review. - RAD51D Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants.
Bueno-Martínez E, Sanoguera-Miralles L, Valenzuela-Palomo A, Lorca V, Gómez-Sanz A, Carvalho S, Allen J, Infante M, Pérez-Segura P, Lázaro C, Easton DF, Devilee P, Vreeswijk MPG, de la Hoya M, Velasco EA. Bueno-Martínez E, et al. Cancers (Basel). 2021 Jun 7;13(11):2845. doi: 10.3390/cancers13112845. Cancers (Basel). 2021. PMID: 34200360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials